Zobrazeno 1 - 10
of 648
pro vyhledávání: '"M. Babcock"'
Autor:
Armaghan-e-Rehman Mansoor, Caroline A. O’Neil, David McDonald, Victoria J. Fraser, Hilary M. Babcock, Jennie H. Kwon, for the CDC Prevention Epicenters Program
Publikováno v:
Antimicrobial Stewardship & Healthcare Epidemiology, Vol 4 (2024)
Between May and June 2021, healthcare personnel at two long-term care facilities underwent SARS-CoV-2 anti-nucleocapsid immunoglobulin G testing and completed a survey on COVID-19 exposures and symptoms. Antibody positivity rate was 8.9%. Similar rat
Externí odkaz:
https://doaj.org/article/bff366d321fe479aba49d7a3bc110c6b
Autor:
Sudipto K. Chakrabortty, Yevgenia L. Khodor, Robert R. Kitchen, Dulaney L. Miller, Kailey M. Babcock, Kyle S. Manning, Steven P. Lang, Vasisht Tadigotla, Wei Yu, Eric Bershad, Johan Skog, Susana Zanello
Publikováno v:
npj Microgravity, Vol 8, Iss 1, Pp 1-9 (2022)
Abstract Molecular profiling to characterize the effects of environmental exposures is important from the human health and performance as well as the occupational medicine perspective in space exploration. We have developed a novel exosome-based plat
Externí odkaz:
https://doaj.org/article/7713ca03e5524ed589651bd4b3983ad3
Autor:
Rachel E. Bosserman, Christopher W. Farnsworth, Caroline A. O’Neil, Candice Cass, Daniel Park, Claire Ballman, Meghan A. Wallace, Emily Struttmann, Henry Stewart, Olivia Arter, Kate Peacock, Victoria J. Fraser, Philip J. Budge, Margaret A. Olsen, Carey-Ann D. Burnham, Hilary M. Babcock, Jennie H. Kwon, for the CDC Prevention Epicenters
Publikováno v:
Antimicrobial Stewardship & Healthcare Epidemiology, Vol 3 (2023)
Abstract Objective: To determine the prevalence of severe acute respiratory coronavirus virus 2 (SARS-CoV-2) IgG nucleocapsid (N) antibodies among healthcare personnel (HCP) with no prior history of COVID-19 and to identify factors associated with s
Externí odkaz:
https://doaj.org/article/002815063179414c9efb6253f98afc47
Autor:
Abby Sung, Adam L. Bailey, Henry B. Stewart, David McDonald, Meghan A. Wallace, Kate Peacock, Candace Miller, Kimberly A. Reske, Caroline A. O’Neil, Victoria J. Fraser, Michael S. Diamond, Carey-Ann D. Burnham, Hilary M. Babcock, Jennie H. Kwon
Publikováno v:
Frontiers in Cellular and Infection Microbiology, Vol 12 (2022)
Immunocompromised adults can have prolonged acute respiratory syndrome coronavirus 2 (SARS-CoV-2) positive RT-PCR results, long after the initial diagnosis of coronavirus disease 2019 (COVID-19). This study aimed to determine if SARS-CoV-2 virus can
Externí odkaz:
https://doaj.org/article/1628e0ac67304c2cb6f727a37f4685cb
Autor:
Rachel E. Bosserman, Christopher W. Farnsworth, Caroline A. O’Neil, Candice Cass, Daniel Park, Claire Ballman, Meghan A. Wallace, Emily Struttmann, Henry Stewart, Olivia Arter, Kate Peacock, Victoria J. Fraser, Philip J. Budge, Margaret A. Olsen, Carey-Ann D. Burnham, Hilary M. Babcock, Jennie H. Kwon, for the CDC Prevention Epicenters
Publikováno v:
Antimicrobial Stewardship & Healthcare Epidemiology, Vol 2 (2022)
In a prospective cohort of healthcare personnel (HCP), we measured severe acute respiratory syndrome coronavirus virus 2 (SARS-CoV-2) nucleocapsid IgG antibodies after SARS-CoV-2 infection. Among 79 HCP, 68 (86%) were seropositive 14–28 days after
Externí odkaz:
https://doaj.org/article/9b04a25b79924f0fa6e2770940fd9882
Publikováno v:
Antimicrobial Stewardship & Healthcare Epidemiology, Vol 2 (2022)
Externí odkaz:
https://doaj.org/article/d897420b7df24254b9d3e09a2e23d035
Autor:
Michael P. Stevens, Sharon B. Wright, Keith S. Kaye, Jerry M. Zuckerman, Catherine L. Passaretti, Richard A. Martinello, Hilary M. Babcock, Michael B. Edmond, Graham M. Snyder
Publikováno v:
Antimicrobial Stewardship & Healthcare Epidemiology, Vol 2 (2022)
Hospitals are increasingly consolidating into health systems. Some systems have appointed healthcare epidemiologists to lead system-level infection prevention programs. Ideal program infrastructure and support resources have not been described. We in
Externí odkaz:
https://doaj.org/article/805bc51a3fed4136b6485a2d6f347737
Autor:
Katelin B. Nickel, Victoria J. Fraser, Hilary M. Babcock, Jennie H. Kwon, for the CDC Prevention Epicenters Program
Publikováno v:
Antimicrobial Stewardship & Healthcare Epidemiology, Vol 2 (2022)
Coronavirus disease 2019 (COVID-19) vaccine effectiveness in the early months of vaccine availability was high among healthcare personnel (HCP) at 88.3% for 2-doses. Among those testing positive for severe acute respiratory coronavirus virus 2 (SARS-
Externí odkaz:
https://doaj.org/article/b5833f069fc644caa2a6b7b0b7389af4
Autor:
Rishi Rattan, Jeffry Nahmias, Areg Grigorian, Brandon Bruns, Paul J Chestovich, Jose L Pascual, Patrick Bosarge, Rindi Uhlich, Parker Hu, Allison G McNickle, Grace Chang, Todd W Costantini, Lawrence Lottenberg, John Berne, Chance Spalding, Leigh Anna Robinson, Lauren M Turco, Bryce Robinson, Joshua G Corsa, Michael Mount, Amy V Hamrick, Dalier R Mederos, Jason Weinberger, Jane K Lee, Kevin L Chow, Erik J Olson, Rachele Solomon, Danielle A Pigneri, Husayn A Ladhani, Joanne Fraifogl, Jeffrey Claridge, Terry Curry, Manasnun Kongwibulwut, Haytham Kaafarani, Janika San Roman, Craig Schreiber, Anna Goldenberg-Sandau, Nicole Lunardi, Farooq Usmani, Joseph Victor Sakran, Jessica M Babcock, Juan Carlos Quispe, Donna Cabral, Jhoanna Gulmatico, Jonathan J Parks, Jennifer Massetti, Onaona Gurney, Alison A Smith, Chrissy Guidry, Matthew E Kutcher, Melissa S Logan, Michelle Y Kincaid, Matthew Noorbaksh, Frances H Philp, Benjamin Cragun, Robert D Winfield
Publikováno v:
Trauma Surgery & Acute Care Open, Vol 4, Iss 1 (2019)
Introduction Gunshot wounds to the brain (GSWB) confer high lethality and uncertain recovery. It is unclear which patients benefit from aggressive resuscitation, and furthermore whether patients with GSWB undergoing cardiopulmonary resuscitation (CPR
Externí odkaz:
https://doaj.org/article/9251387fae6d419d9a5c614fd0a27aa1
Autor:
Nathaniel M, Lewis, Wesley H, Self, Manjusha, Gaglani, Adit A, Ginde, David J, Douin, H, Keipp Talbot, Jonathan D, Casey, Nicholas M, Mohr, Anne, Zepeski, Shekhar A, Ghamande, Tresa A, McNeal, Nathan I, Shapiro, Kevin W, Gibbs, D Clark, Files, David N, Hager, Arber, Shehu, Matthew E, Prekker, Heidi L, Erickson, Michelle N, Gong, Amira, Mohamed, Nicholas J, Johnson, Vasisht, Srinivasan, Jay S, Steingrub, Ithan D, Peltan, Samuel M, Brown, Emily T, Martin, Arnold S, Monto, Akram, Khan, Laurence W, Busse, Caitlin C Ten, Lohuis, Abhijit, Duggal, Jennifer G, Wilson, Alexandra June, Gordon, Nida, Qadir, Steven Y, Chang, Christopher, Mallow, Carolina, Rivas, Hilary M, Babcock, Jennie H, Kwon, Matthew C, Exline, Adam S, Lauring, Natasha, Halasa, James D, Chappell, Carlos G, Grijalva, Todd W, Rice, Jillian P, Rhoads, Ian D, Jones, William B, Stubblefield, Adrienne, Baughman, Kelsey N, Womack, Christopher J, Lindsell, Kimberly W, Hart, Yuwei, Zhu, Katherine, Adams, Manish M, Patel, Mark W, Tenforde
Publikováno v:
Clinical Infectious Diseases. 75:S159-S166
Background . Adults in the United States (US) began receiving the adenovirus vector coronavirus disease 2019 (COVID-19) vaccine, Ad26.COV2.S (Johnson & Johnson [Janssen]), in February 2021. We evaluated Ad26.COV2.S vaccine effectiveness (VE) against
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1d4efe6f52aace78e5793a53d83a0ad8
https://doi.org/10.1093/cid/ciac439
https://doi.org/10.1093/cid/ciac439